title: Splice variants DNMT3B4 and DNMT3B7 overexpression inhibit cell proliferation in 293A cell line.
abstract: DNA methyltransferase 3B (DNMT3B) is critical in abnormal DNA methylation patterns in cancer cells. Nearly 40 alternatively spliced variants of DNMT3B have been reported. DNMT3B4 and DNMT3B7 are two kinds of splice variants of DNMT3B lacking the conserved methyltransferase motif. In this study, the effect of inactivation of DNMT3B variants, DNMT3B4 and DNMT3B7, on cell proliferation was assessed. pCMV-DNMT3B4 and pCMV-DNMT3B7 recombinant plasmids were developed and stably transfected into 293A cells. 293A cells transfected with plasmid pCMV-DNMT3B4 or pCMV-2B were then treated with G418 to the stable cell lines. After that, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method was used for testing the proliferation level, and flow cytometry was used to test cell cycle distribution of the cell line. The expression of p21 was detected by real-time PCR and Western blot. The methylation status of p21 promoter was detected by methylation-specific PCR (MS-PCR). It was found that DNMT3B4 and DNMT3B7 overexpression could inhibit cell proliferation and increase the expression of p21. Cell cycle analysis demonstrated that inactivation of DNMT3B variants overexpression inhibited cell cycle progression. Inactivation of DNMT3B variants overexpression facilitated p21 expression to delay 293A cell proliferation. These findings indicate that inactivation of DNMT3B variants might play an important role in cell proliferation correlating with the change of p21.
authors: Department of Pathology, Guangdong Medical College, Guangdong, People's Republic of China. shao.guo.china@gmail.com
authors: Guo
authors: G
authors: Shao
authors: Ran
authors: R
authors: Zhang
authors: Shu
authors: S
authors: Zhang
authors: Shuyuan
authors: S
authors: Jiang
authors: You
authors: Y
authors: Liu
authors: Wei
authors: W
authors: Zhang
authors: Yanbo
authors: Y
authors: Zhang
authors: Jinping
authors: J
authors: Li
authors: Kerui
authors: K
authors: Gong
authors: Keri
authors: K
authors: Gong
authors: Xin-Rong
authors: XR
authors: Hu
authors: Shi-Wen
authors: SW
authors: Jiang
mesh_terms: D015153:Blotting, Western; D049109:Cell Proliferation; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation / Q000235:genetics*; D017931:DNA Primers / Q000235:genetics; D005434:Flow Cytometry; D005786:Gene Expression Regulation / Q000502:physiology*; D020868:Gene Silencing; D005839:Gentamicins; D057809:HEK293 Cells; D006801:Humans; D010957:Plasmids / Q000235:genetics; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods; D013778:Tetrazolium Salts; D013844:Thiazoles; D000097584:DNA Methyltransferase 3B
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; D004248:DNA (Cytosine-5-)-Methyltransferases; D017931:DNA Primers; D005839:Gentamicins; D020033:Protein Isoforms; D013778:Tetrazolium Salts; D013844:Thiazoles; D000097584:DNA Methyltransferase 3B; C493956:CDKN1A protein, human; C010680:antibiotic G 418; C022616:thiazolyl blue
references: Nucleic Acids Res. 1994 Jan 11;22(1):1-10
references: 8127644
references: Mol Cancer Res. 2009 Oct;7(10):1622-34
references: 19825994
references: Nucleic Acids Res. 2010 Oct;38(18):6054-64
references: 20507910
references: Proc Soc Exp Biol Med. 1996 Nov;213(2):138-49
references: 8931660
references: Int J Oncol. 2006 Jul;29(1):201-7
references: 16773201
references: Cancer Res. 2006 Sep 1;66(17):8361-6
references: 16951144
references: Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
references: 10325416
references: Oncogene. 2007 Aug 16;26(38):5553-63
references: 17353906
references: Trends Genet. 2008 Jan;24(1):7-10
references: 18054115
references: Int J Oncol. 2005 Mar;26(3):757-61
references: 15703834
references: Nat Genet. 1998 Jul;19(3):219-20
references: 9662389
references: J Cancer Res Clin Oncol. 2004 Nov;130(11):636-44
references: 15490234
references: Oncol Rep. 2010 Mar;23(3):819-26
references: 20127025
references: J Biol Chem. 2001 Jun 1;276(22):19610-6
references: 11259405
references: Biochem Biophys Res Commun. 2009 Apr 24;382(1):171-6
references: 19275888
references: Oncogene. 2008 Jun 5;27(25):3615-23
references: 18223691
references: J Biol Chem. 2000 Mar 3;275(9):6353-9
references: 10692435
references: Cancer Res. 2012 Sep 15;72(18):4714-23
references: 22815530
references: Cancer Res. 2010 Jul 15;70(14):5840-50
references: 20587527
references: J Pathol. 2006 Oct;210(2):147-54
references: 16850502
references: Clin Cancer Res. 2004 May 15;10(10):3438-43
references: 15161699
references: J Cell Biochem. 2006 Aug 1;98(5):1230-48
references: 16514663
references: Eur J Dermatol. 2009 Mar-Apr;19(2):141-6
references: 19153068
references: Nat Cell Biol. 2011 Dec 04;14(1):73-9
references: 22138576
references: Cancer Res. 2002 Apr 15;62(8):2378-84
references: 11956100
references: Cancer Res. 2007 Nov 15;67(22):10647-52
references: 18006804
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10060-5
references: 12110732